Position Summary:
You will be joining the External Innovation group within the Corporate Development team at Tessera Therapeutics. This group seeks external relationships, including existing technologies and co-development opportunities, to augment Tessera’s internal R&D efforts, in addition to working with the Corporate Development team to support Tessera’s BD initiatives. You will be performing due diligence, literature search/analyses, and supporting our licensing initiatives. Additionally, you will have the opportunity to interact with a dynamic scientific team to perform your analyses and assessments. This position is uniquely suited for a candidate who is interested in bringing a deeply scientific approach to business development.
Key Responsibilities:
The successful candidate will work both independently and as part of a collaborative team to:
- Develop a deep understanding of Tessera’s interests, motivations, and platforms to identify external, complementary opportunities.
- Read and analyze scientific literature in diverse scientific fields such as genome editing, biomolecule delivery, transposable elements, and beyond to seek seemingly unrelated discoveries in natural biology that could be harnessed for Gene Writing technologies.
- Build and maintain a landscape of emerging technologies that align with Tessera’s short- and long-term enterprise goals.
- Collaborate with the BD team to perform deep scientific and technical diligence to guide BD initiatives.
- Build, collate, and organize external technology databases.
- Communicate key findings and analyses to the BD team, as well as to relevant members of the Tessera community.
- Manage and prioritize projects to align with External Innovation goals
Preferred Qualifications:
- Currently enrolled in a bachelor’s degree in Biology, Biochemistry, or a related discipline with an interest in genetic medicine, business development, and biotechnology
- At least two years of an undergraduate education completed
- Familiarity with molecular biology
- Familiarity and interest in the pharmaceutical/biotech industry
- Preference for candidates with interest or experience in IP or technology transfer
- The ability to provide and present analytical insights on complex topics
- The ability to communicate concisely and effectively
More About Flagship Pioneering
Flagship Pioneering has conceived of and created companies such as Moderna Therapeutics (NASDAQ: MRNA), Editas Medicine (NASDAQ: EDIT), Omega Therapeutics (NASDAQ: OMGA), Seres Therapeutics (NASDAQ: MCRB), and Indigo Agriculture. Since its launch in 2000, Flagship has applied its unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures. In 2021, Flagship Pioneering was ranked 12th globally on Fortune’s “Change the World” list, an annual ranking of companies that have made a positive social and environmental impact through activities that are part of their core business strategies.
Flagship Pioneering and our ecosystem companies are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.
Recruitment & Staffing Agencies: Flagship Pioneering and its affiliated Flagship Lab companies (collectively, “FSP”) do not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.
